Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml is a potent, non-narcotic, non-steroidal, analgesic agent with anti-inflammatory and anti-pyretic activity for horses and cattle. For horses it is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders and for the alleviation of visceral pain associated with colic. For cattle it is indicated for the control of pyrexia associated with bovine respiratory disease, acute bovine mastitis and inflammation in endotoxemia.
What is Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml?
Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml is a potent, non-narcotic, non-steroidal, analgesic agent with anti-inflammatory and anti-pyretic activity for horses and cattle.
Who is Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml for?
Horses and Cattle
Why use Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml?
-Treats pain and lameness in horses
-Reduce inflammation caused by musculoskeletal disorders
-Helps control pyrexia associated with bovine respiratory disease in cattle
-Fast acting relief
How does Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml work?
Flunixin meglumine is used to relieve pain and inflammation in horses and cattle and for its antipyretic properties. Vetameg injectable is a part of the non-steroidal anti-inflammatory class of drugs (NSAIDs). Flunixin persists in inflammatory tissues and is associated with anti-inflammatory properties which extend well beyond the period associated with detectable plasma drug concentration.
Aspen Veterinary Resources
Flunixin Meglumine 50 mg/ml
How is Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml sold?
100 ml and 250 ml vials
What are the side effects of Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml?
Horse: There are no known contraindications to this drug when used as directed. Intra-arterial injection should be avoided. Horses inadvertently injected intra-arterially can show adverse reactions. Signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. Signs are transient and disappear without antidotal medication within a few minutes. Do not use in horses showing hypersensitivity to flunixin meglumine.
Cattle: There are no known contraindications to this drug in cattle when used as directed. Do not use in animals showing hypersensitivity to flunixin meglumine. Use judiciously when renal impairment or gastric ulceration are suspected.
* In horses, isolated reports of local reactions following intramuscular injection, particularly in the neck, have been received. These include localized swelling, sweating, induration, and stiffness. In rare instances in horses, fatal or nonfatal clostridial infections or other infections have been reported in association with intramuscular use of flunixin meglumine. In horses and cattle, rare instances of anaphylactic-like reactions, some of which have been fatal, have been reported, primarily following intravenous use.
What special precautions are there?
Keep away from children and animals. Cattle must not be slaughtered for human consumption within 4 days of the last treatment. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Not for use in dry dairy cows. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Not for use in horses intended for food.
Contact your nearest emergency animal hospital
How can I store Vetameg (Flunixin Meglumine) Injectable, 50 mg/ml?
Store between 2°C - 30°C (36°F - 86°F) Protect From Freezing.
Use as directed by your veterinarian.
Horse: The recommended dose of Flunixin Meglumine for musculoskeletal disorders is 0.5 mg per pound (1 mL/100 lbs) of body weight once daily. Treatment may be given by intravenous or intramuscular injection and repeated for up to 5 days. Studies show onset of activity is within 2 hours. Peak response occurs between 12 and 16 hours and duration of activity is 24-36 hours. The recommended dose for the alleviation of pain associated with equine colic is 0.5 mg per pound of body weight. Intravenous administration is recommended for prompt relief. Clinical studies show pain is alleviated in less than 15 minutes in many cases. Treatment may be repeated when signs of colic recur. During clinical studies approximately 10% of the horses required one or two additional treatments. The cause of colic should be determined and treated with concomitant therapy.
Cattle: The recommended dose of Flunixin Meglumine for the control of pyrexia associated with bovine respiratory disease and endotoxemia and the control of inflammation in endotoxemia, is 1.1 to 2.2 mg/kg (0.5 to 1 mg/lb; 1 to 2 mL per 100 lbs) of body weight given by slow intravenous administration either once a day as a single dose or divided into two doses administered at 12-hour intervals for up to 3 days. The total daily dose should not exceed 2.2 mg/kg (1.0 mg/lb) of body weight. Avoid rapid intravenous administration of the drug. The recommended dose for acute bovine mastitis is 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) of body weight given once by intravenous administration.
Each milliliter of Vetameg 50 mg/mL contains flunixin meglumine equivalent to 50 mg flunixin, 0.1 mg edetate disodium, 2.5 mg sodium formaldehyde sulphoxylate, 4.0 mg diethanolamine, 207.2 mg propylene glycol, 5.0 mg phenol as preservative, hydrochloric acid, water for injection q.s.